Syneos Health Identifies Important Drivers of Change Expected to Disrupt Healthcare
February 11, 2021 08:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, is pulsing a series of 2021 Health Trends –...
Syneos Health Schedules Fourth Quarter and Full Year 2020 Earnings Call for Thursday, February 18, 2021
January 26, 2021 18:37 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and full year...
Syneos Health to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021 16:15 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...
Syneos Health Acquires Illingworth Research Group, a Leading Provider of Clinical Research Home Health Services
December 18, 2020 09:14 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 18, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of Illingworth...
Syneos Health Completes Acquisition of Synteract
December 10, 2020 08:59 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that it has completed the...
Syneos Health to Outline Value Creation Plan at 2020 Analyst and Investor Event
December 07, 2020 17:18 ET
|
Syneos Health, Inc.
Unique Product Development Model Delivers Accelerated Growth Presentation Begins at 9:00 A.M. ET on Tuesday, December 8 MORRISVILLE, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Syneos Health®...
Syneos Health and ConcertAI Announce Strategic Collaboration to Accelerate the Use of Real World Evidence and AI to Advance Oncology Research
December 03, 2020 08:49 ET
|
Syneos Health, Inc.
BOSTON and MORRISVILLE, N.C., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization and ConcertAI, the leader in oncology...
Syneos Health Announces Pricing of Secondary Offering of Common Stock
December 02, 2020 08:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
Syneos Health Announces Secondary Offering of Common Stock
December 01, 2020 16:21 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
Syneos Health Announces Closing of Offering of $600.0 Million of Senior Notes Due 2029
November 24, 2020 18:07 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...